Doxofylline (SR) 600 mg & Montelukast 10 mg Tablets

Buy Doxofylline (SR) 600 mg & Montelukast 10 mg Tablets for Bulk Order

What is Doxofylline (SR) 600 mg & Montelukast 10 mg Tablets?

Doxofylline (SR) 600 mg & Montelukast 10 mg Tablets are pharmaceutical formulations designed to manage respiratory conditions, primarily asthma and chronic obstructive pulmonary disease (COPD). Doxofylline is a xanthine derivative, while Montelukast is a leukotriene receptor antagonist. Both compounds work synergistically to improve airflow and reduce inflammatory responses.

These tablets are essential in the pharmaceutical industry for treating various respiratory ailments, synthesized through established chemical processes compliant with industry standards. Regulatory relevance includes adherence to guidelines set forth by agencies such as the FDA and EMA.

What Are the Applications of Doxofylline (SR) 600 mg & Montelukast 10 mg Tablets?

• Management of asthma and COPD symptoms
• Research applications in respiratory pharmacology
• Formulation development for combination therapies
• Investigational use in clinical trials

Why Choose Pharmint as Your Doxofylline (SR) 600 mg & Montelukast 10 mg Tablets Supplier?

Pharmint offers global sourcing capabilities, ensuring the highest quality of Doxofylline (SR) 600 mg & Montelukast 10 mg Tablets. We provide Certificates of Analysis (COA), Material Safety Data Sheets (MSDS), and ensure regulatory compliance. Our bulk availability, efficient lead times, and export support set us apart from typical vendors, delivering value to procurement teams and R&D laboratories.

Storage & Handling Guidelines for Doxofylline (SR) 600 mg & Montelukast 10 mg Tablets

Store Doxofylline (SR) 600 mg & Montelukast 10 mg Tablets in a cool, dry place away from light and moisture. The optimal storage temperature is between 15°C to 25°C (59°F to 77°F). Ensure the packaging is intact and suitable for bulk or research-grade material to maintain potency and integrity.

Regulatory, Documentation & Export Information

This product does not require an end-use declaration and is not classified as a controlled precursor. Available documentation includes COA and MSDS, ensuring compliance with international regulations and facilitating smooth export processes.

Doxofylline (SR) 600 mg & Montelukast 10 mg Tablets FAQs

1. What are the key benefits of Doxofylline and Montelukast?

Doxofylline and Montelukast work together to alleviate asthma symptoms, providing bronchodilation and anti-inflammatory effects for improved respiratory function.

2. How should I store these tablets?

Store at controlled room temperature (15°C to 25°C), away from light and moisture to maintain efficacy.

3. Is a regulatory compliance document available?

Yes, we provide COA and MSDS to ensure compliance with safety and regulatory standards for bulk procurement.

4. Can these tablets be used in research?

Yes, they are suitable for research applications, particularly in studying respiratory pharmacology and formulation development.

5. What is the lead time for bulk orders?

Pharmint ensures efficient lead times for bulk orders, supported by our global sourcing and logistics capabilities.